Patents Assigned to Gambro Lundia AB
  • Patent number: 11979472
    Abstract: A digital communication module for a self-contained medical device communication platform is disclosed herein. In an example, a digital communication module is communicatively coupled to a therapy module of a medical device for relaying medical device data to an electronic medical record (“EMR”) server that is connected to a medical network. The digital communication module is connected to at least one other digital communication module via a wireless proprietary network that is separate from the medical network. The digital communication module determines that the medical device data from the medical device is to be transmitted, via the wireless proprietary network, to one of the other digital communication modules that is connected to the EMR server via the medical network. The other of the digital communication modules receives, and then routes the medical device data to the EMR server via the medical network.
    Type: Grant
    Filed: June 2, 2021
    Date of Patent: May 7, 2024
    Assignee: Gambro Lundia AB
    Inventors: Bernd Wittner, Aghohgo Ekpruke
  • Patent number: 11975130
    Abstract: A system and a method for renal replacement therapy includes a blood treatment unit connected to a blood circuit and a dialysis fluid circuit, the system further including a control unit configured to control the system according to control instructions during a treatment, so as to determine a system parameter value and an indication of membrane fouling of the membrane, and activate an automatic anti-fouling measure that includes a temporary change of the flow rate in the blood circuit and a temporary decrease of the ultrafiltration rate wherein a timing of the temporary change and a timing of the temporary reduction are synchronized.
    Type: Grant
    Filed: June 21, 2018
    Date of Patent: May 7, 2024
    Assignee: GAMBRO LUNDIA AB
    Inventors: Roger Nilsson, Björn Ericson, Jan Sternby, Thomas Hertz, Olof Jansson, Sture Hobro, Anders Wallenborg, Jonas Fors, Henrik Lindgren, Annmargret Håkansson
  • Patent number: 11969529
    Abstract: The exemplary systems and methods may generate treatment records for extracorporeal blood treatments. The treatment records may include a plurality of values of various parameters. The various parameters may include a compulsory set of parameters that are preset, a dependent set of parameters that a dependent on one or more of a selected treatment and a system configuration, and a discretionary set of parameters that are selected by a user.
    Type: Grant
    Filed: November 22, 2017
    Date of Patent: April 30, 2024
    Assignee: Gambro Lundia AB
    Inventors: Roger Nilsson, Roland Persson, Bendik Torvin
  • Patent number: 11967417
    Abstract: The present disclosure relates to a system comprising a filtration and/or diffusion device and an editable dataset comprising data pertaining to the filtration and/or diffusion device.
    Type: Grant
    Filed: July 29, 2019
    Date of Patent: April 23, 2024
    Assignee: GAMBRO LUNDIA AB
    Inventors: Till Goldammer, Thomas Ertl
  • Patent number: 11957890
    Abstract: A warming unit (21) coupled or configured to be coupled to a heated portion (19) of a fluid circuit (6, 7, 10, 11, 13, 14, 15; 107) of a medical device (1, 100). The warming unit (21) comprises a leakage current reduction circuit (35) configured to perform the following procedure: connecting a heat transfer element (22) of the warming unit (21) to a ground connection (33) through a resistance element (34), which keeps a normal condition patient leakage current below a first limit value, and disconnecting the heat transfer element (22) from the ground connection (33) if a current indicating that a patient is connected to a mains voltage is sensed through the resistance element (34), in order to keep a fault condition patient leakage current below a second limit value.
    Type: Grant
    Filed: June 25, 2019
    Date of Patent: April 16, 2024
    Assignee: Gambro Lundia AB
    Inventors: Michael Jon Wangen, Daniel Edward Ruhland, Randy A. Miller
  • Patent number: 11955234
    Abstract: Graphical user interfaces for use with extracorporeal blood treatment systems may include a plurality of mini settings cards corresponding to a plurality of settings cards. The mini settings cards may display one or more user-interactable settings, and may be selected to display the corresponding settings card. Further, each settings card may be accessed in other ways to selection of mini settings card such as, for example, by selection of a process feature graphical element corresponding the settings card.
    Type: Grant
    Filed: June 27, 2017
    Date of Patent: April 9, 2024
    Assignee: Gambro Lundia AB
    Inventors: Bendik Torvin, Par-Olof Hakansson, Maria Johnsson, AnnMargret Hakansson, Roger Nilsson
  • Patent number: 11951244
    Abstract: A fluid temperature control device for an extracorporeal blood treatment apparatus, comprises: a casing (26) delimiting a heating/cooling seat (20) configured to accommodate a fluid warming bag (17) connected or connectable to an extracorporeal blood treatment apparatus (1); heating elements (29, 30) operatively active in the heating seat (20) to heat the fluid warming bag (17); at least a presence detector (32, 33) operatively active in the heating seat (20) to detect the presence of the fluid warming bag (17). The presence detector (32, 33) comprises an electromagnetic transmitter (34) and an electromagnetic receiver (35).
    Type: Grant
    Filed: May 10, 2019
    Date of Patent: April 9, 2024
    Assignee: Gambro Lundia AB
    Inventor: Michael Jon Wangen
  • Patent number: 11951240
    Abstract: A CRRT apparatus comprising a filtration unit (2), a blood circuit (17), a blood pump (21), a dialysate line (13) and one or more lines (8; 51; 57; 58; 63; 69; 67; 74) to transfer a respective solution into blood; a fluid source for each of said one or more lines, wherein said solution comprises at least one buffer agent in the form of bicarbonate or bicarbonate precursor. A control unit (12) is configured to receive a patient prescription and to determine a parameter (Jbuffer_load/BW) indicative of a steady state acid-base balance in the blood of the patient who has to undergo a CRRT blood treatment, wherein said parameter is determined as a function of the concentration of said buffer agent in said fluid source and as a function of the estimated or calculated patient systemic steady state concentration of bicarbonate and/or bicarbonate precursors.
    Type: Grant
    Filed: December 23, 2020
    Date of Patent: April 9, 2024
    Assignee: Gambro Lundia AB
    Inventor: Dominique Pouchoulin
  • Patent number: 11951295
    Abstract: An apparatus (1) for CRRT is provided comprising a blood circuit (10, 20, 30, 60) with a blood removal line (20), a treatment unit (10), and a blood return line (30). A replacement fluid container (78) is configured for containing a medical fluid, a pre-infusion line (70) has a first end (70-1) connected to the replacement fluid container (78) and a second end (70-2) connected to the blood removal line (20) and a blood pump (22) is active on the blood circuit. A replacement fluid pump (72) is active on the pre-infusion line (70), a dialysate circuit (40, 50, 70) comprises an effluent line (50) configured for discharging fluid from the second chamber, and a control unit (80) is connected to the replacement fluid pump (72) and to the blood pump (22) and is configured for performing a rinse-back procedure for restituting blood to a patient.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: April 9, 2024
    Assignee: Gambro Lundia AB
    Inventors: Thierry Court, Dominique Pouchoulin
  • Patent number: 11944732
    Abstract: An extracorporeal therapy system includes: (i) a dialysis fluid circuit including dialysis fluid preparation structure to prepare a dialysis fluid for treatment, the dialysis fluid circuit including a fresh dialysis fluid pump, a used dialysis fluid pump, and at least one filter for purifying the dialysis fluid; (ii) a blood circuit including a blood filter for use during the treatment; (iii) a blood pump operable to pump blood through the blood circuit and blood filter; (iv) a source of disinfecting fluid; and (v) a control unit operable with the dialysis fluid preparation structure and the blood pump, the control unit programmed to cause the disinfecting fluid to be delivered to and located for a duration at an area of the dialysis fluid circuit having the at least one purifying filter, and wherein during the duration the disinfecting fluid is precluded from contacting at least the fresh dialysis fluid pump.
    Type: Grant
    Filed: March 7, 2019
    Date of Patent: April 2, 2024
    Assignee: Gambro Lundia AB
    Inventors: Sture Hobro, Helena Jeppsson, Björn Ericson
  • Patent number: 11939251
    Abstract: A peritoneal dialysis system includes a cycler including a pump actuator, a heater and a heating pan operable with the heater, and a disposable set operable with the cycler. The heating pan includes a sidewall forming a slot. The disposable set includes a pumping cassette and a heater/mixing container. The pumping cassette includes a pump chamber configured to be actuated by the pump actuator. Additionally, the heater/mixing container is in fluid communication with the pumping cassette and is sized to be received at the heating pan. The heater/mixing container includes a port configured such that when the port is slid into the slot of the heater pan sidewall, the port is prevented from rotating about an axis transverse to a direction of flow through the port.
    Type: Grant
    Filed: October 1, 2020
    Date of Patent: March 26, 2024
    Assignee: Gambro Lundia AB
    Inventors: Jane E. Fitzgerald, Ryan P. Marry, John S. Norman, James D. Ascenzo, Meng-Yang Chen, Anders Wellings, Edward S. Szpara, Olof Jansson
  • Patent number: 11931493
    Abstract: A control system is configured to implement a method of preparing a blood treatment apparatus (1) for blood treatment. The method comprises installing, by use of a disposable arrangement, first and second flow circuits (C1, C2) separated by a semi-permeable membrane (25), the first flow circuit (C1) being connected for fluid communication with the apparatus (1) and the second flow circuit (C2) being connected to form a closed loop that includes a sterilizing filter (46) and, optionally, a container (30). The method further comprises performing backfiltration to transfer a human-compatible fluid from the first flow circuit (C1) to the second flow circuit (C2) through the semi-permeable membrane (25), and circulating (304) the human-compatible fluid in the closed loop of second flow circuit (C2), to thereby sterilize the human-compatible fluid by the sterilizing filter (46) and, optionally, collect a resulting sterile fluid in the container (30) for later use.
    Type: Grant
    Filed: November 18, 2019
    Date of Patent: March 19, 2024
    Assignee: Gambro Lundia AB
    Inventors: Roger Nilsson, Björn Ericson, Jonas Fors, Karl Henrik Forsland
  • Patent number: 11918772
    Abstract: A fluid sampling or infusion device for an extracorporeal blood treatment apparatus comprises: a protective body (29) having a first aperture (30) and a second aperture (31) and comprising a connecting device (28) configured to connect, optionally in removable manner, the protective body (29) to a sampling or infusion site (20) of the extracorporeal blood treatment apparatus (1); a needle assembly (33) comprising a first end (34) connected or connectable, optionally in removable manner, to a syringe (22) and a needle (35) protruding from a second end opposite the first end (34). The needle assembly (33) is movable inside the protective body (29) between a first position and a second position. In the first position the needle (35) is completely enclosed by the protective body (29) and in the second position the needle (35) protrudes from the second aperture (31) to pierce the sampling or infusion site (20).
    Type: Grant
    Filed: June 19, 2019
    Date of Patent: March 5, 2024
    Assignee: Gambro Lundia AB
    Inventor: Guillaume Vernin
  • Patent number: 11908563
    Abstract: A machine for extracorporeal blood treatment includes a user interface having a touch screen and a controller programmed to display on a screen (16) a display in which two distinct areas are arranged, one of which (161) exhibits a series of touch keys (17), wherein activation of any one touch key (17) causes visualization of an image in a second area (162) of the screen, wherein the images are displayed alternatively and are at least partly different one from another, wherein each touch key (17) is associated to an instruction, or to a group of instructions, each concerned with readying the machine for use, wherein each image is a pictograph of a configuration of the machine, correlated with an instruction associated to the touch key (17) selected, and wherein the operator is aided in making the machine ready for treatment.
    Type: Grant
    Filed: October 5, 2020
    Date of Patent: February 20, 2024
    Assignee: Gambro Lundia AB
    Inventors: Massimo Zaccarelli, Lorenza Ferrarini, Danielle Pelletier, Jeffrey J. Letteri
  • Patent number: 11896752
    Abstract: A dialysis machine configured to carry out a method and a method for draining an extracorporeal fluid circuit utilizing a dialysis machine, wherein the dialysis machine is connected to a dialyzer and said extracorporeal fluid circuit, said extracorporeal fluid circuit comprising an arterial line connectable to a patient, for drawing blood from the patient and a venous line connectable to the patient for returning blood to the patient, the method comprising: after treatment termination from said extracorporeal fluid circuit draining remaining fluid from said extracorporeal fluid circuit through the dialyzer.
    Type: Grant
    Filed: October 25, 2018
    Date of Patent: February 13, 2024
    Assignee: Gambro Lundia AB
    Inventors: Sture Hobro, Roger Nilsson, Olof Jansson, Björn Ericson
  • Patent number: 11890401
    Abstract: Dialysis machines comprising a feed arrangement to supply a dialysis fluid to a dialyzer during dialysis treatment and a return arrangement to remove the dialysis fluid from the dialyzer during dialysis treatment and forward it to an exit; a feed recirculation circuit to allow a fluid of the feed arrangement to be re-circulated in a fluid loop path comprising, at least a portion of, the feed arrangement and the feed recirculation circuit and a return recirculation circuit to allow a fluid of the return arrangement to re-circulate in an auxiliary fluid loop path comprising, at least a portion of, the return arrangement and the return recirculation circuit. A controller configured to perform disinfection by re-circulating a disinfectant and/or a heated fluid through said fluid loop path and/or through said auxiliary fluid loop path.
    Type: Grant
    Filed: February 24, 2022
    Date of Patent: February 6, 2024
    Assignee: Gambro Lundia AB
    Inventors: Helena Jeppsson, Jan Sternby, Thomas Hertz, Olof Jansson, Sture Hobro, Evi Martinson
  • Patent number: 11883571
    Abstract: An extracorporeal blood treatment apparatus includes a filtration unit (2) connected to a blood circuit (17) and a dialysate circuit (32), a preparation device (9) for preparing and regulating the composition of the dialysis fluid, and a sensor (11) for measuring conductivity of the dialysate (i.e. spent dialysis fluid); a control unit (12) configured for setting a sodium concentration in the dialysis fluid and after setting the dialysis fluid at the initial set point, circulating the dialysis fluid and blood through the filtration unit (2), measuring an initial conductivity value of the dialysate at the beginning of the treatment, and calculating, based on the measured initial conductivity value and on the corresponding conductivity value of the dialysis fluid, the value of the initial plasma conductivity, said circulating of the dialysis fluid up to the calculating of the initial plasma conductivity performed by maintaining the dialysis fluid conductivity substantially constant.
    Type: Grant
    Filed: April 15, 2020
    Date of Patent: January 30, 2024
    Assignee: Gambro Lundia AB
    Inventors: Paolo Rovatti, Alessandro Surace, Carlo Alberto Lodi, Anders Wallenborg, Anders Nilsson, Kristian Solem, Jan Sternby, Thomas Hertz
  • Patent number: 11883573
    Abstract: A renal failure therapy system includes a dialysis fluid circuit including a dialysis fluid pump; a source of physiological cleaning, disinfecting, and/or decalcifying substance in fluid communication with the dialysis fluid circuit; a source of purified water in fluid communication with the dialysis fluid circuit; and a logic implementer in operable communication with the dialysis fluid pump, the logic implementer causing the physiological cleaning, disinfecting, and/or decalcifying substance from its source to be added to purified water from the purified water source to form a mixture and to circulate the mixture within the dialysis fluid circuit using the dialysis fluid pump to at least one of clean, disinfect or decalcify at least a portion of the dialysis fluid circuit without a subsequent rinse.
    Type: Grant
    Filed: June 24, 2021
    Date of Patent: January 30, 2024
    Assignee: Gambro Lundia AB
    Inventors: Sture Hobro, Jonas Fors, Olof Jansson
  • Patent number: 11872335
    Abstract: An extracorporeal blood treatment apparatus is provided comprising a filtration unit connected to a blood circuit and to a dialysis fluid circuit, a preparation device for preparing and regulating the composition of the dialysis fluid; a control unit is configured for determining or receiving a proposed value of a sodium concentration for the dialysis fluid in the dialysis supply line and to determine a set value for the sodium concentration in the dialysis fluid as a function of the proposed value. For at least an interval of proposed values for the sodium concentration, the control unit is configured to determine the set value so that the set value is different from the proposed value and so that distinct set values are determined from distinct proposed values. The set value is biased towards a predetermined pivot value.
    Type: Grant
    Filed: November 8, 2016
    Date of Patent: January 16, 2024
    Assignee: Gambro Lundia AB
    Inventor: Thomas Hertz
  • Patent number: D1009930
    Type: Grant
    Filed: July 13, 2020
    Date of Patent: January 2, 2024
    Assignee: Gambro Lundia AB
    Inventors: Jonathan Lucas, John O'Mahony, Steve Bernard, Thomas Lendway, Jonas Schaefer, Mike Hanson